The IMID Forum
The Immune-Mediated Inflammatory Disease Forum
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Notable Guests
Episodes (421)
Insights at ACR 2020: Day 1 Beyond RA Highlights
The IMID Forum
Discussing Rheumatology: Baricitinib and Itacitinib
The IMID Forum
Insights at ACR 2020: Preview
The IMID Forum
Perspectives in Inflammation - Prof Bijlsma
The IMID Forum
Perspectives in Inflammation - Prof Azevedo
The IMID Forum
Rheumatology Author Kevin Winthrop: Infections in Baricitinib Clinical Trials
The IMID Forum
Rheumatology Author: Dr Eugen Feist and Dr Pedro López-Romero
The IMID Forum
Discussing Rheumatology: JAK Inhibitor Infection and Cardiovascular Risks
The IMID Forum
Perspectives in Inflammation - Prof Anja Strangfeld and Prof Loreto Carmona
The IMID Forum
Perspectives in Inflammation - Prof Leonard Calabrese
The IMID Forum
Rheumatology Author Vibeke Strand: Upadacitinib Monotherapy
The IMID Forum
Perspectives in Inflammation - Dr Enrique Soriano
The IMID Forum
Discussing Rheumatology: JAK Inhibitor Monotherapy in RA
The IMID Forum
Rheumatology Author Roy Fleischmann: Baricitinib Monotherapy
The IMID Forum
Rheumatology Author Kosuke Ebina: Drug Retention
The IMID Forum
Perspectives in Inflammation - Prof Chris Ritchlin
The IMID Forum
Rheumatology Author Georg Schett: SARS-CoV-2
The IMID Forum
Discussing Rheumatology: PsA and Drug Retention
The IMID Forum
Perspectives in Inflammation – Prof Maurizio Cutolo
The IMID Forum
Perspectives in Inflammation - Prof Chris Buckley
The IMID Forum
Rheumatology Author Axel Finckh: Drug Maintenance
The IMID Forum
Rheumatology Author Prof Gerd Burmester: PsA & Hep B
The IMID Forum
Rheumatology Author Dr Stanley Cohen: Fenebrutinib
The IMID Forum
Discussing Rheumatology: Baricitinib Safety and Treatment Interruptions
The IMID Forum
Insights at EULAR 2020: Safety Of JAK Inhibitors
The IMID Forum
Insights at EULAR 2020: Basic Science
The IMID Forum
Insights at EULAR 2020: Clinical Data on JAK Inhibitors
The IMID Forum
Insights at EULAR 2020: PRO & Real World
The IMID Forum
Insights at EULAR 2020: Beyond RA
The IMID Forum
Insights at EULAR 2020: Day 4 Highlights
The IMID Forum
Insights at EULAR 2020: Day 3 Highlights
The IMID Forum
Insights at EULAR 2020: Day 2 Highlights
The IMID Forum
Insights at EULAR 2020: Day 1 Highlights
The IMID Forum
Insights at EULAR 2020: Preview
The IMID Forum
Discussing Rheumatology: PsA & Hep B
The IMID Forum
COVID-19 Global Rheumatology Registry
The IMID Forum
Discussing Rheumatology: Vasculitis & Zoster
The IMID Forum
Rheumatology Author Prof Kevin Winthrop: Zoster
The IMID Forum
Rheumatology Registries for COVID-19
The IMID Forum
COVID-19: Considerations for Rheumatologists
The IMID Forum
Perspectives in Inflammation – Prof Pierre Miossec
The IMID Forum
Rheumatology Author Interview: Bone Homeostasis
The IMID Forum
Rheumatology Author Prof Georg Schett: Osteoblasts
The IMID Forum
Discussing Rheumatology: JAKi and Bone Biology
The IMID Forum
Perspectives in Inflammation - Prof Iain McInnes
The IMID Forum
Rheumatology Author Dr Orsolini: Osteoimmunology
The IMID Forum
Discussing Rheumatology: JAK Selectivity
The IMID Forum
Perspectives in Inflammation - Prof Anca Catrina
The IMID Forum
Rheumatology Author Prof Vibeke Strand: PROs
The IMID Forum
Discussing Rheumatology: Tofacitinib Improves PROs
The IMID Forum